C-Rad ABLTS:0R44 87 Market Cap is kr1,197.2 Mil as of Jul. 01, 2026. GuruFocus rates LTS:0R44 with a GF Score™ of 87/100 and a GF Value™ of kr33.48 (Fairly Valued). The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, C-Rad AB ranks better than 50.58% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). C-Rad AB's share price for the quarter that ended in Mar. 2026 was kr26.25. C-Rad AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 33.0 Mil. Therefore, C-Rad AB's market cap for the quarter that ended in Mar. 2026 was kr865.8 Mil.
C-Rad AB's quarterly market cap
declined
from Sep. 2025 (kr1,090.4 Mil) to Dec. 2025 (kr1,029.6 Mil) and
declined
from Dec. 2025 (kr1,029.6 Mil) to Mar. 2026 (kr865.8 Mil).
C-Rad AB's annual market cap
declined
from Dec. 2023 (kr1,411.0 Mil) to Dec. 2024 (kr1,029.2 Mil) but then
increased
from Dec. 2024 (kr1,029.2 Mil) to Dec. 2025 (kr1,029.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. C-Rad AB's Enterprise Value for Today is kr1,071.4 Mil.
C-Rad AB (LTS:0R44) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
C-Rad AB Market Cap Related Terms
C-Rad AB Market Cap Historical Data
* Premium members only.
The historical data trend for C-Rad AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, C-Rad AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-Rad AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Market Cap distribution charts can be found below:
* The bar in red indicates where C-Rad AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
C-Rad AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
C-Rad AB (LTS:0R44) has a Market Cap of kr1,197.2 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C-Rad AB and its competitors. According to the industry distribution chart, C-Rad AB ranks #429 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is C-Rad AB's Market Cap too high?
C-Rad AB's current Market Cap is kr1,197.2 Mil. Based on the distribution chart, C-Rad AB ranks #429 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, C-Rad AB has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does C-Rad AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, C-Rad AB ranks #429 out of 868 companies for Market Cap. This puts C-Rad AB in the upper half of its industry. The industry median Market Cap is 118.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.46, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C-Rad AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-Rad AB's current Market Cap is kr1,197.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-Rad AB stock overvalued right now?
Based on GuruFocus' analysis, C-Rad AB (LTS:0R44) is currently considered Fairly Valued. The stock's GF Value™ is kr33.48, compared to a current price of kr35.90 — trading 7.2% above its estimated fair value. The current Market Cap is kr1,197.2 Mil. C-Rad AB's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For C-Rad AB (LTS:0R44), the current Market Cap is kr1,197.2 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-Rad AB (LTS:0R44) Overvalued in 2026?
Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued.
The current stock price of kr35.90 is trading 7.2% above its estimated GF Value™ of kr33.48.
GuruFocus considers C-Rad AB to be Fairly Valued.
Key valuation signals for LTS:0R44:
Market Cap: kr1,197.2 Mil
GF Value™: kr33.48 vs. price of kr35.90 (7.2% above fair value)
No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
87GF Score
Get the complete analysis for LTS:0R44
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0R44 has been successfully added to your 
